Delivery Order SPE2DB22D3501-SPE2DB25FWV33
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,255.90 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rocuronium 50 mg/5 ml vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 19, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded contract, issued without set-aside provisions, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,902.07. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,346.81. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract uses firm fixed pricing and represents a relatively small-value transaction under the company's larger pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,105.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 ml vials totaling $1,166.98 under firm fixed pricing. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on September 3, 2025. This non-set-aside, competitively awarded contract carries a ceiling value of $1,166.98 under a firm fixed-price arrangement, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials valued at $1,105.56 on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for Rocuronium 50 mg/5 ml vials with a ceiling value of $1,126.08. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV33Delivery Order
The Defense Logistics Agency awarded a $1,006.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Rocuronium 50 mg/5 mL vials. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement likely supporting military or federal healthcare operations through DLA's medical supply chain. This award is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement requirements through competitive awards and demonstrates significant capacity to meet DLA's pharmaceutical distribution needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/12/25 |